"Figure F-92 is titled ""Change in CAPS for atypical antipsychotics compared with placebo."" The figure displays a forest plot reporting the weighted mean difference in CAPS scores for atypical antipsychotics versus placebo stratified by risperidone versus placebo and olanzapine versus placebo. The plot depicts greater reductions in CAPS scores for patients treated with risperidone (4 trials, weighted mean difference −4.60, 95% CI −9.01 to −0.20, I2=22.3%) or olanzapine (1 trial, weighted mean difference −12.13, 95% CI −23.29 to −0.97) than placebo. The overall analysis favored atypical antipsychotics (weighted mean difference −5.76, 95% CI −10.35 to −1.17, I2=30.7%)."